Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Association between supraglottic airway device use and respiratory adverse events during airway management in children with airway hyperresponsiveness: a report from the Japan Paediatric Difficult Airway in Anaesthesia (J-PEDIA) registry.

Created on 30 Sep 2026

Authors

Yuka Uchinami, Takashi Soejima, Shingo Nishida, Yusuke Yamauchi, Fumio Watanabe, Shogo Ichiyanagi, Yu Kaiho, Taiki Kojima, J-PEDIA

Published in

British journal of anaesthesia. Sep 29, 2026. Epub Sep 29, 2026.

Abstract

Children with airway hyperresponsiveness face higher risks of perioperative respiratory adverse events. Although the use of supraglottic airway devices (SADs) is associated with fewer perioperative respiratory adverse events than tracheal intubation in selected paediatric populations, evidence remains limited regarding induction-phase airway management in children with airway hyperresponsiveness. We aimed to investigate the association between SAD placement (vs tracheal intubation) and respiratory adverse events during induction-phase airway management in children with airway hyperresponsiveness using propensity score-based inverse probability of treatment weighting.
This multicentre retrospective cohort study was conducted at 12 tertiary-care institutions (six paediatric and six mixed adult-paediatric university hospitals) in the Japan Paediatric Difficult Airway in Anaesthesia registry between July 2022 and February 2025. We included children aged <18 yr undergoing general anaesthesia who had an active upper respiratory tract infection, an upper respiratory tract infection within the preceding 14 days, asthma exacerbation, or household smoking exposure. The primary outcome was the occurrence of respiratory adverse events.
Of the 27 844 encounters, 4878 were analysed (tracheal intubation 3005 of 4878 [61.6%]; SAD 1873 of 4878 [38.4%]). After adjustment, SAD placement was associated with a lower risk of respiratory adverse events (adjusted risk ratio [aRR] 0.41; 95% confidence interval [CI] 0.19-0.62; P<0.001), airway management-related adverse events (aRR 0.32; 95% CI 0.19-0.45; P<0.001), and severe oxygen desaturation (aRR 0.47; 95% CI 0.19-0.75; P<0.001).
Overall, SAD use during induction of anaesthesia was associated with a lower risk of adverse respiratory events in children with airway hyperresponsiveness. These findings support consideration of SADs when clinically appropriate while acknowledging potential residual confounding.

PMID:
42810867
Bibliographic data and abstract were imported from PubMed on 30 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 27
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement